Skip to content

HRMY

Harmony Biosciences Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$42.25
+0.93%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+30.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 18, 2026Graf R. Mark · directorA-Award21,872$31
May 18, 2026Sender Gary · directorA-Award21,872$31
May 18, 2026Philip Ron M · directorA-Award21,872$31
May 18, 2026Sabater Juan A. · directorA-Award21,872$31
May 18, 2026Budur Kumar · officer: CHIEF MEDICAL OFFICERM-Exempt18,750$0.00
May 18, 2026Budur Kumar · officer: CHIEF MEDICAL OFFICERF-InKind8,882$32
May 18, 2026Reicin Glenn · officer: CHIEF FINANCIAL OFFICERA-Award164,309$29
May 18, 2026Germano Geno J · directorA-Award21,231$31
May 18, 2026Szyper Linda M · directorA-Award21,872$31
Apr 9, 2026Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICERM-Exempt7,500$0.00
Apr 9, 2026Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICERF-InKind3,173$28
Apr 6, 2026Anastasiou Peter · officer: CHIEF OPERATING OFFICERA-Award212,241$28
Apr 6, 2026Ignelzi Troy A. · directorA-Award17,710$28
Jan 28, 2026Kapadia Sandip · officer: CHIEF FINANCIAL OFFICERSale3,746$37
Jan 26, 2026Budur Kumar · officer: CHIEF MEDICAL OFFICERF-InKind1,372$37
Jan 26, 2026Budur Kumar · officer: CHIEF MEDICAL OFFICERF-InKind1,153$37
Jan 26, 2026Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICERA-Award56,900$37
Jan 26, 2026Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICERA-Award16,200$0.00
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOA-Award184,600$37
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOA-Award52,900$0.00
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOM-Exempt13,000$0.00
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOM-Exempt10,500$0.00
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOF-InKind5,654$37
Jan 26, 2026Dayno Jeffrey M. · director, officer: PRESIDENT, CEOF-InKind4,785$37
Jan 26, 2026Budur Kumar · officer: CHIEF MEDICAL OFFICERM-Exempt2,188$0.00
Jan 26, 2026Kapadia Sandip · officer: CHIEF FINANCIAL OFFICERA-Award12,200$0.00
Jan 26, 2026Kapadia Sandip · officer: CHIEF FINANCIAL OFFICERM-Exempt3,813$0.00
Jan 26, 2026Kapadia Sandip · officer: CHIEF FINANCIAL OFFICERF-InKind2,553$37
Jan 26, 2026Kapadia Sandip · officer: CHIEF FINANCIAL OFFICERF-InKind2,239$37
Jan 26, 2026Serafin Andrew · officer: CHIEF STRATEGY OFFICERA-Award42,600$37
Institutional positioning

13F filings over the trailing two quarters

New 97Increased 264Reduced 210Sold out 35
FilerActionSharesFiled
BlackRock, Inc.Increased7,101,965Aug 7, 2026
BLACKROCK, INC.Reduced7,070,035May 13, 2026
FMR LLCIncreased3,574,115Aug 13, 2026
FMR LLCIncreased3,157,639May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased2,880,489Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position2,714,353May 8, 2026
AMERICAN CENTURY COMPANIES INCIncreased2,539,512Aug 12, 2026
DIMENSIONAL FUND ADVISORS LPIncreased2,393,588Aug 11, 2026
AMERICAN CENTURY COMPANIES INCIncreased2,105,179May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,105,053Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,102,315May 15, 2026
DIMENSIONAL FUND ADVISORS LPIncreased2,076,510May 7, 2026
LSV ASSET MANAGEMENTIncreased2,061,242Aug 6, 2026
LSV ASSET MANAGEMENTIncreased2,025,143May 11, 2026
SG AMERICAS SECURITIES, LLCIncreased2,018,174Apr 16, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 18, 2026